Physician profile
Prabhat Kumar
NPI 1831778281
$1,033.32
in general payments reported to CMS, 2019-2025
13 companies · $330 in 2025
The $330 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $68.31 · 2022: $271 · 2023: $211 · 2024: $152 · 2025: $330.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $525 · Education: $169.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $524.57 |
| Education | $168.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $200.02 | 2022-2024 | Veklury |
| Janssen Biotech, INC. | $168.99 | 2024-2025 | Tremfya, Stelara |
| Boehringer Ingelheim Pharmaceuticals, INC. | $115.03 | 2022-2023 | Jardiance |
| Genzyme Corporation | $114.21 | 2025 | |
| Exact Sciences Corporation | $100.00 | 2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Merck Sharp & Dohme LLC | $60.38 | 2022-2023 | Recarbrio, Dificid, Zerbaxa |
| Insmed, INC. | $55.13 | 2022 | |
| Abbvie INC. | $48.28 | 2022-2023 | |
| La Jolla Pharmaceutical Company | $37.75 | 2023 | Xerava |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.37 | 2024 | Lifevest |
| Boston Scientific Corporation | $17.78 | 2025 | Resolution 360 Clip |
| Alexion Pharmaceuticals, INC. | $14.58 | 2022 | |
| Conmed Corporation | $13.49 | 2025 | Conmed Generators, Conmed Hemostasis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prabhat Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.